1601-纳米酶靶向RIG-I诱导细胞广谱凋亡增强癌症免疫治疗 episode artwork

EPISODE · Sep 23, 2026 · 25 MIN

1601-纳米酶靶向RIG-I诱导细胞广谱凋亡增强癌症免疫治疗

from 聊聊Sci

这项研究开发了一种名为 Hemin-His-Mn 的新型肿瘤靶向纳米酶,旨在通过诱导PANoptosis(一种结合了凋亡、焦亡与坏死的混合细胞死亡模式)来增强癌症免疫治疗。该纳米酶具有双重功能:它既能作为激动剂解除 RIG-I 蛋白的自身抑制,触发 PANoptosome 复合物的组装,又能利用其类过氧化物酶活性产生大量活性氧以加速细胞死亡。这种机制能显著释放损伤相关分子模式(DAMPs),将“冷”肿瘤转变为“热”肿瘤,从而激活T细胞介导的抗肿瘤免疫反应。实验证明,该疗法能有效重塑肿瘤免疫微环境,并与免疫检查点阻断协同作用,为克服临床免疫耐药提供了极具潜力的临床转化方案。References:Dong S, Yuan Y, Cao H, et al. A RIG-I targeting nanozyme induces PANoptosis for cancer immunotherapy[J]. Nature Communications, 2026, 17: 6311.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Sep 23, 2026

Embed this episode

Ready to play

1601-纳米酶靶向RIG-I诱导细胞广谱凋亡增强癌症免疫治疗

0:00 25:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 25 minutes long.

When was this 聊聊Sci episode published?

This episode was published on September 23, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!